BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10756784)

  • 1. [The importance of immunohistochemical examination in the diagnosis of malignant lymphoproliferative diseases--the author's personal experience].
    Căruntu ID
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):129-33. PubMed ID: 10756784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine needle aspiration biopsy. Applications in the diagnosis of lymphoproliferative diseases.
    Frable WJ; Kardos TF
    Am J Surg Pathol; 1988; 12 Suppl 1():62-72. PubMed ID: 3354761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of immunohistochemical technics to the study of malignant infiltration of bone marrow].
    Delsol G; Al Saati T; Faure PH; Caverivière P; Chittal S; Rigal-Huguet F; Robert A; Laurent G; Pris J
    Pathol Biol (Paris); 1988 Jan; 36(1):11-6. PubMed ID: 3283666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 cases of malignant immunoblastic lymphomas].
    Căruntu ID; Mihăilă D
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):205-8. PubMed ID: 10756800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases].
    Krivolapov IuA; Peshkov MV; Leenman EE; Matsionis AE; Kovrigina AM
    Arkh Patol; 2011; 73(2):25-32. PubMed ID: 21695985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative disorders associated with carbamazepine.
    Katzin WE; Julius CJ; Tubbs RR; McHenry MC
    Arch Pathol Lab Med; 1990 Dec; 114(12):1244-8. PubMed ID: 2252421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anatomicopathological considerations in the clinical study of malignant non-Hodgkin's lymphomas in children].
    Căruntu ID; Mihăilă D; Mănescu M; Dobrescu G; Savu B
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):90-4. PubMed ID: 9455442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
    Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
    Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
    Deegan MJ
    Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell lymphoma or Hodgkin's disease in a HIV seropositive patient: a histopathological study.
    Kanavaros P; Nemeth J; Lavergne A; Ngo Van P; Galian A
    Histol Histopathol; 1989 Oct; 4(4):493-8. PubMed ID: 2485199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus distribution in nonneoplastic lymph nodes.
    Deamant FD; Albújar PF; Chen YY; Weiss LM
    Mod Pathol; 1993 Nov; 6(6):729-32. PubMed ID: 8302816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen.
    Salter DM; Krajewski AS; Dewar AE
    J Pathol; 1985 Aug; 146(4):345-53. PubMed ID: 2411901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From genes to antibodies: the antipeptide approach to the immunocytochemical study of human malignant lymphoproliferative diseases.
    Mason DY
    Nouv Rev Fr Hematol (1978); 1991; 33(2):97-102. PubMed ID: 1766863
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
    Sadek I; Greer W; Foyle A
    Clin Invest Med; 2000 Dec; 23(6):366-75. PubMed ID: 11152404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders.
    Cerroni L; Kerl H
    Dermatol Clin; 1994 Apr; 12(2):219-29. PubMed ID: 8045034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry.
    Warnke R; Pederson M; Williams C; Levy R
    Am J Clin Pathol; 1978 Dec; 70(6):67-75. PubMed ID: 103428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
    Cartun RW; Coles FB; Pastuszak WT
    Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
    Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
    Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical analysis and cytomorphologic diagnosis on fine needle aspirates of lymphoproliferative disease.
    Tani EM; Christensson B; Porwit A; Skoog L
    Acta Cytol; 1988; 32(2):209-15. PubMed ID: 3348061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.